MYRANDA PRATHER: Open Payments
NPI 1275142903 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 13 payments from 9 companies in 2025. Trend: 2023 $319 · 2024 $181 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $120 |
| Genentech USA, Inc. | 3 | $56 |
| Octapharma USA, Inc. | 2 | $48 |
| ARGENX US, INC. | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| CSL Behring | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
Products named: ULTOMIRIS, OCTAGAM IMMUNE GLOBULIN (HUMAN), Ocrevus Zunovo, VYVGART, Actemra, NUCALA, HYQVIA, Hizentra.
Industry payments across KS — which companies pay providers there.
